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Abstract: Lycotoxin I and Lycotoxin II are natural anti-microbial peptides that were identified in the venom of the Wolf Spider
Lycosa carolinensis. These peptides were found to be potent growth inhibitors for bacteria (Escherichia coli) and yeast (Candida
glabrata) at micromolar concentrations. Recently, shortened analogues of LycoI and LycoII have been reported to have decreased
haemolytic effects. A shorter Lyco-I analogue studied, LycoI 1–15 (H-IWLTALKFLGKHAAK-NH2), was active only above 10 µM, but
was also the least haemolytic.
On the basis of these findings, we became interested in obtaining a deeper insight into the membrane activity of LycoI 1–15,
as this peptide may represent the first major step for the future development of selective, i.e. non-haemolytic, Lycotoxin-based
antibiotics.
The interaction of this peptide with liposomes of different composition was studied by microcalorimetry [differential scanning
calorimetry (DSC) and isothermal titration calorimetry (ITC)] and CD. The results obtained from the calorimetric and spectroscopic
techniques were jointly discussed in an attempt to further understand the interaction of this peptide with model membranes.
Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd.
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INTRODUCTION
Anti-microbial peptides have been widely studied in the
past years [1–15], as they may become an alternative
to conventional antibiotic therapy, in view of the
growing emergence of multi-resistant microbial strains.
Substantial efforts have been directed to increase
the potency and specificity of these peptides against
pathogenic agents, while minimizing their deleterious
effects towards eukaryotic cells. Although the detailed
mode of action of anti-microbial peptides is not well
established and, further, it is now known that it
differs for distinct peptides, it is clear that all cationic
amphipathic peptides interact with membranes. It has
been proposed that the cytoplasmic membrane is the
main target for some of these peptides, and therefore,
the development of resistance is not to be expected [8].
Lycotoxin I (LycoI, H–IWLTALKFLGKHAAKHLAKQQL
SKL–NH2) and Lycotoxin II (LycoII, H–KIKWFKTMKSIA
KFIAKEQMKKHLGGE–OH) are natural anti-microbial
peptides that were identified in the venom of the
Wolf Spider Lycosa carolinensis [16]. They were
found to be potent growth inhibitors for bacteria
(Escherichia coli) and yeast (Candida glabrata) at
micromolar concentrations. Their secondary structure
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was predicted to be an amphipathic α-helix, a structure
that is common in pore-forming peptides [16]. Recently,
these peptides were found to be active against
Leishmania donovani promastigotes and Leishmania
pifanoi amastigotes, also at the micromolar range, with
LycoI being the most active peptide [17]. The serious
drawback of these natural peptides (especially LycoI)
is their significant haemolytic activity above 20 µM,
studied against rabbit and sheep erythrocytes [16,17],
which severely limits their potential application as
antibiotics.
The specificity of a drug for bacteria over erythro-
cytes, or its therapeutic index, defined as the ratio of
minimal haemolytic concentration (MHC) to minimal
inhibitory concentration (MIC), can be increased as fol-
lows: (i) by only increasing its anti-microbial activity,
(ii) by decreasing haemolytic activity while maintaining
anti-microbial activity, or (iii) ideally, by combining an
increase in anti-microbial activity with a decrease in
haemolytic activity.
Recently, shortened analogues of LycoI and LycoII
have been reported in a study where C-terminal
shortening of LycoI is shown to lower the pep-
tide’s leishmanicidal activity, but with the advan-
tage of showing decreased haemolytic effects. Thus,
the shorter LycoI analogue studied, LycoI 1–15
(H–IWLTALKFLGKHAAK–NH2) was only active above
10 µM, but was also the least haemolytic of the set
[17]. So, although not all goals described above in
terms of increased therapeutic index were achieved, we
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became interested in obtaining a deeper insight into the
membrane activity of LycoI 1–15, as this peptide may
represent the first major step for the future develop-
ment of selective, i.e. non-haemolytic, Lycotoxin-based
antibiotics.
Differential scanning calorimetry (DSC) has emerged
as a most valuable tool to study peptide–membrane
interactions [1,15,18–23]. DSC analysis provides
a thermodynamic characterization of the changes
induced by peptides on lipid bilayer phase transitions.
Membrane interfaces have the ability to induce se-
condary structure in a wide range of anti-microbial
peptides [21,24–27]. The change in the secondary
structure of the peptide upon interaction with the mem-
branes can be evaluated by CD spectroscopy. Using
isothermal titration calorimetry (ITC), we can deter-
mine the energetics of the interaction of the peptides
with model membranes of different composition.
We herein report the study of the interactions
between the anti-microbial peptide LycoI 1–15 (H-
IWLTALKFLGKHAAK-NH2) and large unilamellar vesi-
cles (LUVs) of three different lipid bilayer systems: zwit-
terionic 1,2-dimyristoyl-sn-glicero-3-phosphocholine
(DMPC), anionic 1,2- dimyristoyl-sn- glycero-3-[phos-
pho- rac-(1-glycerol)] (DMPG) and a DMPC/DMPG (3 : 1)
mixture. The importance of membrane composition
in the interaction processes, as reflected in the dif-
ferences found here, represents a contribution to the
understanding of peptide-induced lipid bilayer perme-
abilization and the mode of action of LycoI 1–15 on
biological level.
MATERIALS AND METHODS
Materials
DMPC and DMPG were obtained from Avanti Polar Lipids
(Alabaster, AL, USA), and used without further purification.
Fmoc-protected amino acids, coupling reagents and resins for
solid-phase peptide synthesis were purchased from Bachem
(Weil am Rhein, Germany). N-(2-hydroxyethyl) piperazine-N ′-
ethane-sulphonic acid (HEPES) was from Sigma Chemical Co.
(St Louis, MO, USA). Ultra pure water (Milli Q Gradient,
Millipore, Billerica, MA, USA) was used in the preparation
of all samples. All other chemicals were from Sigma Chemical
Co. (St Louis, MO, USA).
Preparation of Liposomes
Appropriate amounts of phospholipids (DMPC, DMPG and
DMPC/DMPG (3 : 1)) were dissolved in chloroform (DMPC) or
chloroform/methanol ((3 : 1) v/v) (DMPG and DMPC/DMPG
(3 : 1)). The samples were then dried under a nitrogen stream,
and the film was kept under vacuum for 3 h to remove all
traces of organic solvents. The resulting lipid film was warmed
together with HEPES buffer (10 mM; 0.1 M NaCl; pH = 7.4) in
a thermostated water bath at ca 10 °C above the temperature
of the gel-to-liquid crystalline phase transition (Tm), and then
hydrated at the same temperature. The multi-lamellar vesicles
(MLVs) thus obtained were frozen in liquid nitrogen and
thawed in a water bath at ca 10 °C above Tm, and this process
was repeated 5 times.
LUVs were obtained from the MLVs by extrusion in a 10 ml
stainless steel extruder (Lipex Biomembranes, Vancouver,
BC, Canada), inserted in a thermostated cell with a re-
circulating water bath, at ca 10 °C above Tm. The samples
were passed several times through polycarbonate filters
(Nucleopore, Pleasanton, CA, USA) of decreasing pore size
(600, 200 and 100 nm; 5, 5 and 10 times, respectively), under
inert nitrogen atmosphere.
Size distribution of extruded vesicles was determined
by DLS (Zetasizer nanoZS, Malvern Instruments, Malvern,
Worcestershire, UK) at 37 °C, using a He–Ne laser (wavelength
633 nm) as a source of incident light, and operating at
a scattering angle of 173°. Mean particle size was thus
determined as being (106 ± 4) nm (average and standard
deviation of 6 independent measurements). The phospholipid
concentration was determined by the phosphomolybdate
method [28].
Preparation of Peptides
The peptide was synthesized as C-terminal carboxamides by
Fmoc/tBu solid phase strategies, purified and characterized by
methods as those described in Gomes et al. [29]. Peptide stock
solutions were prepared in HEPES buffer (10 mM; 0.1M NaCl;
pH = 7.4) in the 2–5 mM concentration range, and quantitated
by AAA (amino acid analysis).
Differential Scanning Calorimetry
DSC was performed in a microcalorimeter (Micro-DSCIII,
SETARAM, Caluire, France). The experiments with liposome
suspensions or (liposome + peptides) were run against HEPES
buffer in the reference cell. Blank experiments with HEPES
buffer on both cells were also performed for subsequent
baseline correction. The solution or suspension volume used
in each cell was about 0.8 ml, and the masses of sample
and reference cells were adjusted by weight to ±0.00005 g.
Two successive up- and down-scans were performed for each
sample, the up-scan at a scanning rate of 0.5 °C/min and
the down-scan at 3 °C/min, over a temperature (t) range of
10–35 °C. The sample mixtures were prepared immediately
before the DSC run, by adding the desired amount of
peptide stock solution to the suspension of LUVs. Separate
runs for each liposome suspension without peptide were
also done. All procedures regarding sample preparation and
handling (lag time at low temperature, time between mixture
preparation and start of the experiment) were kept constant
in all experiments to ensure that all samples had the same
thermal history. The instrument was electrically calibrated for
temperature and scan rate.
The Micro-DSCIII software was used for baseline subtrac-
tion, calculation of the gel-to-liquid crystalline phase transition
temperature (Tm) and transition enthalpy (H). Tm and H
were calculated by integration of the heat capacity (Cp) versus
temperature (t) curve. For consistency and comparability, the
integration was always done between the two points: one from
where the curve starts to deviate and the other where it returns
to the baseline.
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Isothermal Titration Calorimetry
The calorimetric technique used was stepwise isothermal
titration microcalorimetry. The water bath and peripheral
units were built at Lund University, and a twin heat
conduction calorimeter (ThermoMetric AB, Ja¨rfa¨lla, Sweden)
was used with a 1 cm3 titration cell equipped with a gold
stirrer. The instrument was electrically calibrated using an
insertion heater [30]. The detailed calorimetric set-up and
basic procedure has been described previously [31]. Briefly,
in each titration, 0.9848 ± 0.0008 ml of liposome suspension
was placed in the titration cell and sequences of successive
injections were made at 4 min intervals (injections with 20 min
interval did not reveal the presence of slow reactions). The
temperature of the measurements was 35 °C throughout, so
that the recorded values refer to the interaction of the peptides
with the liposomes in the fluid phase [1]. Experiments were
performed in the ‘fast titration mode’, the resultant curves
were deconvoluted [32] and the integrals were calculated, and
transformed to heat exchanged by the appropriate calibration
constant. The obtained heats were corrected for the dilution
effects as determined in separate experiments.
The experimental set-up used corresponds to very low
P : L ratios (about 1 : 3000), where 7.006 µl of peptide solutions
(1.4 mM) were injected into the liposome suspension (35 mM)
contained in the cell.
Circular Dichroism
CD measurements were carried out in a Jasco 720 spec-
tropolarimeter, with a 175–800 nm photomultiplier (Japan
Spectroscopic Co., Tokyo), using a cylindrical cell of 1 mm
path length. Experimental conditions were as follows: 0.5 nm
bandwidth, 50 mdeg sensitivity, 1 nm resolution, 1 s time
response, discrete wavelength readings (1 nm). In most cases,
each spectrum was the average of six accumulations but, when
the signal-to-noise ratio was too low, a higher number (up to
24) of accumulations was used. Buffer runs were repeated
throughout the day to check for repeatability. Spectra of pure
liposomes at different concentrations were run as blanks to be
subtracted from the liposome/peptide spectra. After blank cor-
rection, the observed ellipticity was converted to mean residue
molar ellipticity (θ ) (deg cm2 dmol−1).
The measurements in buffer were done with peptide
concentrations of 36 µM, and in the mixtures the peptide
was added to the lipid suspensions immediately before
measurement. A concentration of 6000 µM was used for
DMPC with a peptide–lipid molar ratio of 1 : 79, and a
concentration of 1200 µM for DMPG and DMPC/DMPG (3 : 1)
with a peptide–lipid molar ratio of 1 : 32. All spectra were
recorded at 35 °C, with the temperature kept constant by a
circulating water bath.
RESULTS
In Figure 1, we show a helical wheel representation
of LycoI 1–15, a perfect amphipatic α-helix, with
all charged residues on one face of the helix. This
characteristic indicates that, probably, it will interact
with different types of membranes.
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Figure 1 Helical wheel representation of Lyco I 1–15.
Light grey – polar, non-charged residues; dark grey – polar,
positively charged residues; white – hydrophobic residues.
In Figure 2(A)–(C) we plot the Cp versus t curves
for the gel-to-liquid crystalline phase transition of the
lipid bilayer, at increasing peptide ratios (DMPC, DMPG
and DMPC/DMPG (3 : 1)), respectively. The calculated
thermodynamic parameters are listed in Table 1, where
values for the pure lipid systems are also shown.
Measurements on the same peptide/lipid systems were
always done using a liposome suspension from the
same preparation batch, to avoid slight differences
that might arise from different preparation, as small
differences in Tm and H can be observed for the same
pure lipid system in different preparation batches. The
estimated error between samples is larger and is also
provided in the footnote of Table 1.
It can be seen that LycoI 1–15 interacts with all model
systems, although to a different degree, as reflected
by changes in the transition temperature, Tm and
the enthalpy of the transition, H. For the DMPC
system (Figure 2(A)), both Tm and H decrease as
the peptide content in the mixture increases, whereas
for the DMPG (Figure 2(B)) the temperatures remain
constant and the enthalpies decrease until a molar
ratio of 1 : 71. At the molar ratio of 1 : 23, the curve
with DMPG is completely distorted indicating a high
degree of liposome destruction. As for DMPC, we can
see the onset of two transitions at 1 : 71, one at a lower
temperature and a shoulder at a higher temperature. As
the peptide content increases, the relative importance
of the lower temperature peak also increases, its shape
becomes sharper and its temperature decreases. In
Table 1, we report the values of Tm for both peaks and
the total H, as well as the individual contributions.
In the case of the mixed membrane, although the
general appearance is intermediate between the two
previous systems, the profile is more close to the one
observed with the negatively charged system until a
molar ratio of 1 : 71, as up to this peptide–lipid molar
ratio the curve is not as distorted as in the DMPC
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Table 1 Transition temperatures, Tm, and enthalpy change values, H, for the gel-to-liquid crystal liposome transition as a
function of peptide–lipid molar ratio (P : L) for the three lipid systems
(P : L) ratio DMPC DMPG DMPC/DMPG(3 : 1)
Tm/°Ca Tm/°Cb H/kJ.mol
−1c Tm/°C Tm/°C H/kJ.mol−1 Tm/°C Tm/°C H/kJ.mol−1
Pure lipid 24.7 — 22 23.8 — 26 24.9 — 23
(1 : 143) 24.3 0.4 17 23.6 0.2 23 24.6 0.3 17
(1 : 95) — — — 23.4 0.4 20 24.2 0.7 18
(1 : 71) 23.4 1.3 16 23.0 0.8 21 23.7 1.2 25
(1 : 35) 21.6 3.1 12 (8 + 4) — — — — — —
26.4 −1.7 —
(1 : 23) 20.7 4 15 (8 + 7) 19.6 4.2 19 (6 + 13) — — —
24.7 0 — 24.5 −0.7 —
a The estimated uncertainty in Tm is ±0.3 °C and in H it is ±0.5 kJ mol−1 (for the same liposome suspension) and ±3 kJ mol−1
(for liposome suspensions from different preparations).
b Tm/°C = Tm (pure lipid) − Tm (lipid+peptide)
c The reported enthalpy corresponds to the total peak area and within brackets are the separate enthalpies when a significant
peak splitting is observed.
system. This is to be expected as the electrostatic
contribution to the interaction is very significant.
For all peptide/liposome mixtures, precipitation
and aggregation were observed, which were more
pronounced for the DMPG system. Further, the onset
of precipitation with DMPC was much slower than with
the negatively charged systems.
The ITC tracings for the titration of LycoI 1–15
into DMPC and DMPG suspensions are shown in
Figure 3(A) and (B) LycoI 1–15 interacts exothermally
with both systems, the interaction being strongest
with DMPG. The titrations were performed at very
low peptide–lipid ratios (1 : 3000). After integration of
the observed peaks and correction for dilution of the
peptides into buffer, the enthalpy of interaction (per
mole of total injected peptide) can be calculated as
−39 ± 6 and −63 ± 10 kJ mol−1 for DMPC and DMPG,
respectively. This value will be corrected later to the
peptide content in the membrane using the CD results.
Figure 4 shows the CD spectra of the peptide for the
three model systems. LycoI 1–15 shows predominantly
a random coil structure in HEPES buffer, and forms an
α-helix in the presence of all three membrane systems.
Nevertheless, the characteristic minima at 208 and
222 nm of an α-helix shows the most negative θ values
for DMPG, followed closely by DMPC/DMPG. The CD
spectra for the interaction of LycoI 1–15 with DMPC
shows almost the same position of the minima but
with much smaller θ values, even though we increased
the liposome concentration to 6000 µM (whereas it
was 1200 µM for the other systems). This reflects a
lower partition to the zwitterionic membrane, although
keeping the same secondary structure, as the CD signal
in peptide–liposome systems is a weighed mixture of
the various forms present in solution. Moreover, in
order to get clear results with the zwitterionic system,
we had to incubate the mixture for 1/2 h at 35 °C
prior to measurement, showing that the partition to the
zwitterionic membrane is a slow process, in contrast
to partition to negatively (or partly negatively) charged
systems. We already found the same behaviour in a
previous study involving two anti-microbial peptides
that were hybrids from Cecropin A and Melittin [1].
Considering that the partition to DMPG is 100%
(complete binding) and that the peptide binds to all
systems with the same structure, we can estimate
from the respective θ values at 222 nm that we will
have bound fraction values of ∼89 and ∼38% for the
DMPC/DMPG and DMPC systems, respectively. The
assumption of close to 100% partition to the purely
negatively charged membrane will, indeed, provide an
upper bound to the results, but it is reasonable for our
purpose. From these bound fractions and the known
total amount of peptide present in each case, partition
constants of about 104 and 1.5 × 102 can be derived for
DMPC/DMPG and DMPC systems, respectively. Finally,
from these values we can estimate an upper bound to
the amount of peptide that partitions to DMPC, and use
it to correct the enthalpy value that was obtained by
ITC. The resulting corrected value is −50 kJ mol−1.
DISCUSSION
The biological activity of anti-microbial peptides has
been largely associated to their interaction with
membranes. This interaction indeed depends on both
the peptide and the membrane composition.
The results described above for the interactions
of LycoI 1–15 with three lipid bilayer systems allow
us to shed some light onto the peptide–membrane
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Figure 2 DSC curves obtained for liposomes and Lyco I
(1–15) for pure liposomes and different peptide–lipid molar
ratios (P : L): DMPC (A), DMPG (B), DMPC/DMPG (3 : 1) (C). The
peptide molar ratio for each profile is indicated in the figure.
Lipid concentration was 3.0 ± 0.3 mM in all experiments.
interactions that may possibly underlie the mecha-
nisms of peptide anti-microbial action.
In the case of DMPC, the broadening of the DSC
curves and the decrease in Tm is compatible with
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Figure 3 (A) Raw data (potential difference across the
thermopiles as a function of time) for the titration of Lyco
I 1–15 (c = 1.4 mM) into DMPC suspension in the vessel
(c = 35 mM). The volume per injection was 7.006 µl. (B) Raw
data (potential difference across the thermopiles as a function
of time) for the titration of Lyco I 1–15 (c = 1.5 mM) into DMPG
suspension in the vessel (c = 35 mM). The volume per injection
was 7.006 µl.
a better interaction of the peptide with the liquid-
crystalline phase of DMPC. As shown by other authors
[22,33–35], surface insertion leads to bilayer thinning
and induces an increase in local negative curvature,
explaining both the lowering of Tm and the broadening
of DSC curves. The observed decrease in overall H
as the peptide content increases, together with the
referred appearance of two transitions and precipitation
indicates that either the new transition has a lower
energy or that part of the liposomes is no longer having
a gel-to-liquid crystal transition. The decrease in H
indicates that the peptide is perturbing the hydrocarbon
chain packing as the enthalpy for the main transition
is primarily due to the disruption of intra- and inter-
molecular van der Waals interactions, which leads to
chain melting. These results, thus, suggest that the
peptide does penetrate rather deeply into the bilayer.
The appearance of shoulders in thermograms is
a consequence of a non-ideal mixing behaviour,
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Figure 4 CD spectra (t = 35 °C) for Lyco I(1–15) 36 µM in
aqueous buffer (solid line), and in the presence of LUVs of
DMPC, with P : L ratio of 1 : 79 (-∆-); DMPG, with P : L ratio
of 1 : 32 (-
°
-) and DMPC/DMPG (3 : 1) with P : L ratio of 1 : 32
(-∗-).
which creates a non-homogeneous distribution of the
peptide within the membrane. As a result, regions
of two different coexisting phases, one phase richer
in peptide (lower temperature) and the other lipid-
rich (at the same temperature of the pure lipid or
often at higher temperature) could be formed, and
such domain formation has already been reported
for other peptide/lipid systems [19,22,36]. Our DSC
results are compatible with such events, particularly at
the highest peptide ratios, where two broad transitions
can be observed, each probably corresponding to
a different coexisting phase. This picture, together
with a highly negative enthalpy of partition to the
membrane (ITC) (which is only somewhat smaller
than with DMPG, after correction to the peptide
that partitions to the membrane) and the clear
presence of an α-helix (CD) indicates that LycoI 1–15
strongly interacts with the zwitterionic membranes,
by adopting a helical secondary structure, perturbing
significantly the membrane at increasing peptide
content, eventually leading to membrane disruption
(observed precipitation). It should be stressed that as
the peptide–lipid ratio increases (at 1 : 35 and 1 : 23)
the lower temperature peak is the predominant one
(Table 1).
In the case of the negatively charged membrane
(DMPG), a shoulder at higher temperature is also
apparent at low P : L. The fact that a much more
extensive precipitation was observed for this system
can justify the significant decrease in enthalpy with no
significant decrease in Tm – this can be interpreted as
meaning that part of the liposomes are destroyed, and
the remaining have a nearly unperturbed transition.
Note that Tm for this high temperature peak is the
same as the one for the pure lipid, within the combined
uncertainties (see Table 1).
Finally, as far as the mixed system is concerned,
the more close similarity to the DMPG system clearly
indicates that the positively charged peptide prefers
the negatively charged membrane and the presence
of DMPG becomes overwhelming. Further, it is clear
that the presence of 0.75% zwitterionic lipid is also not
affecting the CD curve much at the low peptide ratio
used (1 : 33). Therefore, at low peptide ratios, there must
be a preferential partitioning to the negatively charged
components of the mixed membrane.
CONCLUSIONS
The shortened analogue of LycoI, LycoI 1–15, was
previously shown to have a lower leishmanicidal activity
than the longer native peptide, being only active above
10 µM, but with the advantage of presenting decreased
haemolytic effects [17].
The peptide adopts a α-helical structure in the
presence of the three model membrane systems used.
Overall, the results showed that the peptide interacts
more strongly with negatively charged lipid bilayers
than with neutral membranes, energetically both (H
of interaction, as determined by ITC, is somewhat more
exothermic for the DMPG system), in terms of partition
(indirectly revealed by the difference in minima depth
at 208 and 222 nm in CD curves) and in terms of
the amount of precipitation/aggregation. Nevertheless,
efficient perturbation of the zwitterionic DMPC systems
was found, which explains the haemolytic activity. This
means that more efforts have to be made towards
structural optimization with the generation of peptides
that will interact much less with neutral membrane
systems. We believe that the low charge and the perfect
amphipathicity of the LycoI 1–15 helix (all charged
residues are in the same face with most hydrophobic
ones on the other side) induce a good compatibility
with the zwitterionic membrane, and therefore, new
peptides of this family should be designed so as to at
least partially disrupt this feature.
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